ArticleBMJ public health2025
Scoping review of dementia primary prevention policies in England: do they balance reach and agency?
Article in BMJ public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The principles of Population-Level Approaches to Dementia Risk Reduction (PLADRR).PLoS medicine · 2026Article
- Assessment of Risk Factors for Cognitive Impairment Accounting for Genetic and Environmental Influences: An Italian Population-Based Twin Study.Brain sciences · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To ascertain the balance of dementia risk reduction policies in England, considering their reach (population-wide vs targeted at specific individuals) and agency (the level of resource required to benefit from the intervention). Design: Scoping review. Data sources: Academic databases (Medline, the Health Management Information Consortium and Overton) and the webpages of relevant national and local government agencies and associated bodies (including: the UK Government, the UK Health Security Agency, National Health Service England, National Institute for Health and Care Excellence and local governments and healthcare organisations from the East of England region) were searched. Eligibility criteria: Any written documents or service webpages from, or endorsed by, governmental organisations or arms-length bodies which describe, recommend or evaluate current or formally proposed interventions for the reduction or control of one or more modifiable risk factors for dementia were included. Policies targeted at people with existing cognitive impairment and/or dementia were excluded. Data extraction and synthesis: Data on policy description, reach and agency were extracted from identified dementia primary prevention policy documents by one author. Policies common to several organisations were grouped, and then synthesised across risk factor group and by tier of government. The numerical balance of policies (between axes of reach and agency) was compared across risk factor group and current policy/proposed status. Results: From a total of 8210 hits, 366 policy documents were included. From these, 79 distinct policies were identified, targeted at dementia (n=3), cardiovascular health (n=23), smoking and alcohol (n=17), depression and social isolation (n=12), air pollution (n=10), low formal education (n=9), hearing impairment (n=3) and traumatic brain injury (n=2). Overall, 67.1% (53/79) of current policies had population-reach, 53.2% (42/79) were considered low-agency and 39.2% (31/79) were both population-reach and low-agency. Conclusions: There is currently a policy balance between population-reach and targeted-reach, and high-agency and low-agency interventions, for dementia risk reduction in England. However, a predominance of population-reach, low-agency interventions may be required to match the scale of the challenge and improve equity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.